ASSIGN: Context-specific genomic profiling of multiple heterogeneous biological pathways

Bioinformatics

Volumn 31, Issue 11, 2015, Pages 1745-1753

  Shen, Ying ^a   Rahman, Mumtahena ^b   Piccolo, Stephen R ^a,c   Gusenleitner, Daniel ^a   El Chaar, Nader N ^c   Cheng, Luis ^c   Monti, Stefano ^a   Bild, Andrea H ^c   Johnson, W Evan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BAYES THEOREM; BREAST TUMOR; COMPUTER PROGRAM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN; PROCEDURES; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BAYES THEOREM; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; RATS; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 84939174972     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv031     Document Type: Conference Paper

References (38)

1. Ashburner, M. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. , 25, 25-29.
2. Avraham, R. and Yarden, Y. (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat. Rev. Mol. Cell Biol. , 12, 104-117.
3. Barbie, D. A. et al. (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature, 462, 108-112.
4. Bazot, C. et al. (2013) Unsupervised Bayesian linear unmixing of gene expression microarrays. BMC Bioinformatics, 14, 99.
5. Bhattacharya, A. and Dunson, D. B. (2011) Sparse Bayesian infinite factor models. Biometrika, 98, 291-306.
6. Bild, A. H. et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439, 353-357.
7. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
8. Cheang, M. C. U. et al. (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. , 14, 1368-1376.
9. Fitzpatrick, R. B. (2008) CPDB: Carcinogenic Potency Database. Med. Ref. Serv. Q. , 27, 303-311.
10. Ganter, B. et al. (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol. , 119, 219-244.
11. George, E. I. and Mcculloch, R. E. (1997) Approaches for Bayesian variable selection. Stat. Sin. , 339-374.
12. Golub, T. R. et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
13. Gustafson, A. M. et al. (2010) Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Transl. Med, 2, 26ra25.
14. Hoeflich, K. P. et al. (2009) In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. , 15, 4649-4664.
15. Hsaing, T. (1975) A Bayesian view on ridge regression. The Statistician, 24, 267-268.
16. Johnson, W. E. et al. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
17. Kanehisa, M. et al. (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. , 42, D199-D205.
18. Klinger, B. et al. (2013) Network quantification of EGFR signaling unveils potential for targeted combination therapy. Mol. Syst. Biol. , 9, 673.
19. Li, B. and Dewey, C. N. (2011) RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics, 12, 323.
20. Liberzon, A. et al. (2011) Molecular signatures database (MSigDB) 3. 0. Bioinformatics, 27, 1739-1740.
21. López-Knowles, E. et al. (2010) PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int. J. Cancer J. Int. Cancer, 126, 1121-1131.
22. Ma, H. and Zhao, H. (2012) FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment. Bioinf. , 28, 2662-2670.
23. McCall, M. N. et al. (2010) Frozen robust multiarray analysis (fRMA). Biostatistics, 11, 242-253.
24. Moestue, S. A. et al. (2013) Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res. BCR, 15, R16.
25. Mortelmans, K. and Zeiger, E. (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. , 455, 29-60.
26. Piccolo, S. R. et al. (2012) A single-sample microarray normalization method to facilitate personalized-medicine workflows. Genomics, 100, 337-344.
27. Piccolo, S. R. et al. (2013) Multiplatform single-sample estimates of transcriptional activation. Proc. Natl. Acad. Sci. , 110, 17778-17783.
28. Pirooznia, M. et al. (2008) A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics, 9, S13.
29. Ringnér, M. et al. (2002) Analyzing array data using supervised methods. Pharmacogenomics, 3, 403-415.
30. Saeys, Y. et al. (2007) A review of feature selection techniques in bioinformatics. Bioinformatics, 23, 2507-2517.
31. Subramanian, A. et al. (2005) Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A, 102, 15545-15550.
32. Sweet-Cordero, A. et al. (2005) An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. , 37, 48-55.
33. Trapnell, C. et al. (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinf. , 25, 1105-1111.
34. Trapnell, C. et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. , 28, 511-515.
35. Van de Vijver, M. J. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. , 347, 1999-2009.
36. Wang, K. et al. (2010) MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. , 38, e178.
37. Weinstein, I. B. (2002) Cancer. addiction to oncogenes-the Achilles heal of cancer. Science, 297, 63-64.
38. West, M. (2003) Bayesian factor regression models in the 'Large p, Small n' Paradigm. Bayesian Statistics, 7, 723-732.